Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (72)	1/12/1999 4:14:00 PM
From: Biomaven	Read Replies (1) of 3158

AMGN weighs in: Headline: Amgen (NASDAQ:AMGN) says would consider acquisitions ====================================================================== SAN FRANCISCO, Jan. 11 (Reuters) - Amgen Corp. President Kevin Sharer said Tuesday the biotech giant would consider acquiring another drug company to bolster its product pipeline. Speaking at the Hambrecht and Quist biotech investor conference here, Sharer said Amgen remains cautious about acquisitions and is not pinning all its growth prospects on such a move. "We're not going to bet Amgen on an acquisition. We're not going to buy someone much bigger than Amgen, but we would not shy away from the right opportunity," he told the conference. Amgen has two billion-dollar drugs but has yet to find a third product to equal its blockbusters Epogen and Neupogen. The company has long been considered an acquisition target although Amgen has repeatedly stated it wishes to remain independent. Copyright 1999, Reuters News Service

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next